Research map: Impact and effectiveness of Australia's 2025 hybrid RSV immunisation program: results from the PAEDS-FluCAN Network

Back to the article

Papers in this map

  1. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies · Erik B von Elm · 2008 · 17695 citations · Cited by this paper
  2. Seroprotection to five vaccine-preventable diseases among children in East New Britain, Papua New Guinea · 2026 · Related
  3. Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis · Harish Nair · 2010 · 2841 citations · Cited by this paper
  4. Vision 2040 in Japan: renewing UHC through community-based health care and health security · 2026 · Related
  5. Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study · Ting Shi · 2017 · 2494 citations · Cited by this paper
  6. HPV vaccination policies and implementation for adolescents in low- and middle-income countries: a scoping review · 2026 · Related
  7. Nirsevimab for Prevention of RSV in Healthy Late-Preterm and Term Infants · Laura L. Hammitt · 2022 · 1053 citations · Cited by this paper
  8. Lifetime health benefits, costs, and cost-effectiveness of salt substitution for stroke survivors in China: a microsimulation modeling study · 2026 · Related
  9. Global disease burden of and risk factors for acute lower respiratory infections caused by respiratory syncytial virus in preterm infants and young children in 2019: a systematic review and meta-analysis of aggregated and individual participant data · Xin Wang · 2024 · 202 citations · Cited by this paper
  10. Cross-level regional and socioeconomic inequalities in step counts: a descriptive epidemiological investigation of 1.5 million Japanese smartphone users · 2026 · Related
  11. Prevalence of respiratory viruses in community-acquired pneumonia in children: a systematic review and meta-analysis · Mitchell T. G. Pratt · 2022 · 126 citations · Cited by this paper
  12. Barriers to accessing newer antibiotics in countries with high burden of bacterial antimicrobial resistant infections—a qualitative study · 2026 · Related
  13. Efficacy, Safety, and Immunogenicity of the MATISSE (Maternal Immunization Study for Safety and Efficacy) Maternal Respiratory Syncytial Virus Prefusion F Protein Vaccine Trial · Eric A. F. Simões · 2025 · 112 citations · Cited by this paper
  14. Accumulation of metabolic multimorbidity and its association with mortality: results from a prospective cohort study among people with HIV in China, 2010–2024 · 2026 · Related
  15. Real-world effectiveness of RSVpreF vaccination during pregnancy against RSV-associated lower respiratory tract disease leading to hospitalisation in infants during the 2024 RSV season in Argentina (BERNI study): a multicentre, retrospective, test-negative, case–control study · Gonzalo Pérez Marc · 2025 · 95 citations · Cited by this paper
  16. Multilevel factors influencing child overweight and obesity in the Pacific Islands · 2026 · Related
  17. Respiratory syncytial virus‐associated hospitalisations in Australia, 2006–2015 · Gemma L. Saravanos · 2019 · 86 citations · Cited by this paper
  18. Making older women more visible in healthy ageing · 2026 · Related
  19. Effectiveness and impact of nirsevimab in Chile during the first season of a national immunisation strategy against RSV (NIRSE-CL): a retrospective observational study · Juan Pablo Torres · 2025 · 53 citations · Cited by this paper
  20. Full 2023–24 season results of universal prophylaxis with nirsevimab in Galicia, Spain: the NIRSE-GAL study · Narmeen Mallah · 2024 · 50 citations · Cited by this paper
  21. Nirsevimab Effectiveness at Preventing RSV-Related Hospitalization in Infants · Marie-Joëlle Jabagi · 2025 · 47 citations · Cited by this paper
  22. Effectiveness and Impact of Maternal RSV Immunization and Nirsevimab on Medically Attended RSV in US Children · Heidi L. Moline · 2025 · 39 citations · Cited by this paper
  23. Risk Factors for Poor Outcomes in Children Hospitalized With Virus-associated Acute Lower Respiratory Infections: A Systematic Review and Meta-analysis · Daira Trusinska · 2024 · 37 citations · Cited by this paper
  24. Effectiveness of nirsevimab in preventing RSV-hospitalisation among young children in Western Australia 2024 · Ushma D. Wadia · 2025 · 37 citations · Cited by this paper
  25. Nirsevimab vs RSVpreF Vaccine for Respiratory Syncytial Virus–Related Hospitalization in Newborns · Marie-Joëlle Jabagi · 2025 · 34 citations · Cited by this paper
  26. Maternal Immunization With RSVpreF Vaccine: Effectiveness in Preventing Respiratory Syncytial Virus–associated Hospitalizations in Infants Under 6 Months in Argentina: Multicenter Case–control Study · Ángela Gentile · 2025 · 31 citations · Cited by this paper
  27. Enhanced placental antibody transfer efficiency with longer interval between maternal respiratory syncytial virus vaccination and birth · Olyvia J. Jasset · 2024 · 28 citations · Cited by this paper
  28. Effectiveness of the maternal RSVpreF vaccine against severe disease in infants in Scotland, UK: a national, population-based case–control study and cohort analysis · Isobel McLachlan · 2025 · 20 citations · Cited by this paper
  29. Paediatric Active Enhanced Disease Surveillance (PAEDS) 2017 and 2018: Prospective hospital-based surveillance for serious paediatric conditions · Jocelynne E McRae · 2020 · 15 citations · Cited by this paper
  30. RSV: an update on prevention and management · David Anthony Foley · 2025 · 10 citations · Cited by this paper
  31. Respiratory syncytial virus epidemiology and effectiveness of infant nirsevimab: 2024 results from the Australian Sentinel Hospital Network (FluCAN-PAEDS) · Christopher C. Blyth · 2026 · 3 citations · Cited by this paper

Source: OpenAlex (CC0)